ToxoTech is a research development biopharmaceutical company that uses expert knowledge in structural biology to design and develop novel toxin-based biological product candidates for the treatment of  neuromuscular and neurological disorders.


The botulinum neurotoxins are clinically proven molecules that have been used for decades to treat an increasing range of medical conditions. ToxoTech developed a unique, patented technology based on a modified botulinum neurotoxin with enhanced receptor interactions which provides improved pharmacological properties.